We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Buying Solutions is now a part of the Government Procurement Service.
Neuraxpharm UK Ltd is recalling specific batches after retesting showed out of specification results. The tabled batches are being recalled as a precautionary measure after testing showed variability of the capsule contents beyond permitted levels.
Information about controlled drugs licences for companies that possess, manufacture, produce or supply controlled drugs in England, Wales or Scotland.
Information for those who have been prescribed Paxlovid.
How to get a parallel import licence for your medicine in the UK, including pharmacovigilance requirements and submitting your application.
Check what side effects people have reported when they've taken a medicine.
Find out how the Prevent programme supports people who are at risk of becoming involved with terrorism through radicalisation.
Guidance on applications and licences for manufacturers & wholesalers, suspended and revoked licences, registrations, exporting medicines, defective medicinal products and fees.
Women using modafinil are being warned of an increased risk of birth defects associated with modafinil use during pregnancy.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Information on good laboratory, manufacturing and distribution practice, good pharmacovigilance practice (GPvP), out-of-specification investigations, inspection metrics and fees.
Information about new applications, post-licensing, advertising, product information and fees.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
How to carry out a clinical trial to apply for a marketing authorisation, manage your authorisation and report safety issues.
Verify the business status of overseas businesses established outside the UK using form VAT66A.
Check if you can get free NHS prescriptions, dental treatment or eye tests - or help with other NHS costs
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
Urgent safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).